1800 202 8726
Lung & chest biopsy

Lung Biopsy: — Getting Enough Tissue for EGFR Testing

The most common reason EGFR and other molecular tests cannot be completed is not a laboratory problem — it is too little tumour tissue from the biopsy. Getting that right on the first attempt saves weeks.

Medically reviewed by Dr. Muralidhar Muddusetty, Surgical Oncologist, MBBS (AIIMS) · MS Surgery (AIIMS) · DNB Surg Onc · MRCS (Edinburgh) · Last reviewed September 2026

  • Core beats aspiration — A core needle biopsy removes a cylinder of tissue. Fine-needle aspiration often yields too few cells for molecular tests.
  • First attempt is the best one — Repeat biopsies carry the same risks again. Choosing the right technique first time matters.
  • TB can look identical to cancer — In India, a lung nodule may be TB. The same biopsy sample is used to test for both.
  • A blood test is sometimes an option — If tissue is genuinely insufficient, a liquid biopsy — a blood test for tumour DNA — can sometimes fill the gap.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

EGFR, ALK, and other molecular tests need solid tumour tissue, not just fluid or scattered cells. A core needle biopsy generally gives more tissue than fine-needle aspiration alone. NCCN guidance treats adequate tissue as a prerequisite for molecular testing, and inadequate yield is the most common reason testing cannot be completed on the first attempt.

Why does the amount of tissue matter for EGFR and molecular testing?

Treating lung cancer today usually depends on the tumour's molecular profile — whether it carries an EGFR mutation, an ALK rearrangement, a KRAS change, or a high PD-L1 score. Each test uses part of the same biopsy sample. Confirming that cancer is present is the first job; providing enough material for all the molecular tests is the second, and it is the one that most often goes wrong.

Fine-needle aspiration draws out loose cells and fluid. It can confirm that abnormal cells are present, but the sample is often too small for multiple molecular tests to run reliably. A core needle biopsy takes a thin cylinder of tissue from inside the nodule, preserving its structure and giving the pathologist enough material to complete a full molecular panel. CT-guided core biopsy carries a genuine risk of pneumothorax; published series reviewed by the American College of Chest Physicians report this in roughly one in five procedures, most of which are small and resolve without treatment.

How to give the biopsy the best chance of being enough

  • Tell your team about every medicine you take, including blood thinners and supplements — some need to be stopped before the procedure.
  • Ask whether a core needle biopsy is planned rather than fine-needle aspiration alone.
  • Ask whether rapid on-site evaluation is available — a quick check of tissue adequacy in the room allows extra passes before you leave the table.
  • Ask whether the remaining sample will be stored. Stored tissue can be used for additional tests later without another procedure.
  • Tell the radiologist if you have had TB before or currently have symptoms such as evening fever, weight loss, or a prolonged cough — this changes what the sample is tested for.
  • Arrange for someone to drive you home. A chest X-ray after CT-guided biopsy is standard, and pneumothorax can appear in the first few hours.

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

What happens if the first biopsy does not give enough tissue?

The pathologist reports whether the sample is sufficient for the tests ordered. If it is not, your oncologist will discuss three paths: repeating the biopsy with a different technique, trying bronchoscopy or an EBUS procedure if the location allows it, or using a liquid biopsy.

A liquid biopsy is a blood test that looks for tumour DNA circulating in the bloodstream. ESMO and IASLC guidance supports its use when tissue is inadequate or a repeat procedure carries too high a risk. Its sensitivity is lower than tissue testing for some markers, so a negative result does not rule out a mutation that a tissue sample might have found.

What if the nodule turns out to be TB rather than cancer?

In India, TB remains common enough that a lung nodule can be TB, lung cancer, or both at the same time. The scan appearances can be identical. The same biopsy sample is typically split: part to pathology for cancer testing and part to microbiology for TB staining and culture.

Tell your team if you have had TB before, received treatment for it, or have a household contact with active TB. That context changes how the sample is processed. If the biopsy is inconclusive, your team may request a sputum test, a TB blood test, or a follow-up scan before arriving at a diagnosis.

Explore 133 more Biopsy by Body Part topics

HUB — Biopsy by Body Part

All Biopsy by Body Part →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Can a blood test replace a lung biopsy for EGFR testing?

A liquid biopsy — a blood test looking for tumour DNA — is a real option when tissue is insufficient or a repeat procedure carries too high a risk. ESMO and IASLC guidance supports it in those situations. It is not a first-line replacement for tissue testing: its sensitivity for some markers is lower, and a negative result does not rule out a mutation that a tissue sample might have found. If tissue is obtainable, tissue remains the first choice.

What is the difference between a core biopsy and fine-needle aspiration for a lung nodule?

Fine-needle aspiration draws out individual cells and fluid. It can confirm that malignant cells are present, but the yield is often too small to run EGFR, ALK, PD-L1, and other molecular tests together. A core needle biopsy uses a slightly larger needle to remove a cylinder of tissue from inside the nodule. That cylinder preserves the tumour's structure and usually provides enough material for a full molecular panel in a single pass.

How long will we wait for EGFR results after a lung biopsy?

Basic pathology usually comes back within a few working days. Molecular tests such as EGFR, ALK, and KRAS take longer — typically one to three weeks, depending on the method and whether the sample is sent to a specialist laboratory. Next-generation sequencing, which tests many markers at once, tends to take the longest. Ask your team when the sample was sent and what the expected turnaround is for the specific tests ordered.

Can the same biopsy sample test for both TB and cancer?

Yes, and this is standard practice in India. The sample is split between pathology, which looks for cancer cells, and microbiology, which stains and cultures for TB organisms. Telling your team about any previous TB, TB treatment, or household contacts before the biopsy allows them to request both tests at the same time. Waiting for a second sample if TB is suspected later wastes days and may mean another procedure.

Is it safe to have a CT-guided biopsy if my breathing is already poor?

That is exactly what your interventional radiologist and pulmonologist will assess before proceeding. Pneumothorax — air entering the space between the lung and chest wall — is a known complication and is more serious in someone with limited breathing reserve. The team may choose bronchoscopy, an EBUS procedure, or a surgical approach rather than CT-guided transthoracic biopsy in that situation. The goal is an adequate sample with a risk proportionate to your current lung function.

What is rapid on-site evaluation and does it improve biopsy success?

Rapid on-site evaluation means a cytologist checks the sample in the room while the procedure is in progress, so the radiologist knows immediately whether adequate tumour tissue has been obtained. If the first pass is insufficient, another can be taken before you leave the table. ACCP-reviewed evidence suggests it reduces inadequate sampling rates. Asking whether this is available for your biopsy is a useful question to raise at your planning appointment.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation